Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Portulaca oleracea seed powder is a botanical preparation derived from the seeds of the purslane plant (*Portulaca oleracea* L.). It is traditionally used in medicine for its antioxidant and anti-atherogenic properties. The powder contains various bioactive compounds, including polyphenols, omega-3 fatty acids (alpha-linolenic acid), and antioxidants. In clinical research, it has been investigated for its anti-dyslipidemic effects, specifically its ability to lower serum levels of low-density lipoprotein cholesterol (LDL-C) and triglycerides (TG) in populations such as obese adolescents. Its mechanism of action is thought to involve the modulation of lipid metabolism and oxidative stress through its high concentration of polyunsaturated fatty acids and phenolic compounds.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on portulaca oleracea seed powder.